CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- 4 Grant or award Director acquired 3,662 shares (grant or award)
- 4 Grant or award Director acquired 4,618 shares (grant or award)
- 4 Shares withheld for taxes Chief Financial Officer gave up 2,775 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Medical Officer gave up 7,397 shares (to pay taxes)
- 4 Grant or award Director acquired 2,650 shares (grant or award)
- 4 Grant or award Director acquired 3,341 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Option exercise Director acquired 1,070 shares (option exercise)
- 4 Grant or award Director acquired 4,259 shares (grant or award)
- 4 Grant or award Director acquired 5,370 shares (grant or award)
- 4 Shares withheld for taxes Chief Business Officer gave up 9,004 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Scientific Officer gave up 2,446 shares (to pay taxes)
- 4 Shares withheld for taxes Chief People Officer gave up 9,004 shares (to pay taxes)
Page 1 of 15 · 295 filings